GSK Investigational Site

Torrette AN 60126

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Eosinophilic Granulomatosis With Polyangiitis, Idiopathic Pulmonary Fibrosis

Studies at this site

• Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) — Running, not enrolling
• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early